GGrantIndex
← Leaderboards

Tuya Pal

H. Lee Moffitt Cancer Ctr &Res Inst

Google Scholar ↗PubMed ↗ORCID ↗
$12,373,521
Attributed
$22,567,348
Total exposure
9
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $5.2M · FY2005–25
$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$33,718,904 · 10

By mechanism

U54$12,915,439 · 3
R01$7,622,794 · 3
UH3$6,381,605 · 1
U01$4,007,947 · 1
UG3$2,127,132 · 1
K07$663,987 · 1

Top collaborators

Others in their field

Top investigators on “Malignant Neoplasms”

Research focus

Malignant NeoplasmsProgramsRecruitDesignBaseCancer CenterIncidenceTennesseeImproved OutcomeInstitutionMortalityFollow-UpTumorSamplingUnited StatesResourcesColorectal CancerCancer TherapyCancer PatientCaringGeographyEvaluationCharacteristicsEvidence Base

Grant awards (48)

CAUSAL: Cohort to Augment the Understanding of Sarcoma Survivorship Across the Lifespan$2,201,003
UH3 · FY2025 · CA
(2/3) MMC, VICC, and TSU: Partners in Eliminating Cancer Disparities$1,454,023
U54 · FY2025 · CA · contact PI
Administrative Core$501,365
U54 · FY2025 · CA · contact PI
CAUSAL: Cohort to Augment the Understanding of Sarcoma Survivorship Across the Lifespan$2,243,832
UH3 · FY2024 · CA
(2/3) MMC, VICC, and TSU: Partners in Eliminating Cancer Disparities$1,507,811
U54 · FY2024 · CA · contact PI
IMProving Care After Inherited Cancer Testing (IMPACT) Study$704,330
U01 · FY2024 · CA · contact PI
Administrative Core$522,500
U54 · FY2024 · CA · contact PI
Disparities in breast cancer treatment using Granulocyte colony-stimulating factors and CDK4/6 inhibitors between African and European ancestry individuals in two large Electronic Health Records$200,000
U54 · FY2024 · CA · contact PI
CAUSAL: Cohort to Augment the Understanding of Sarcoma Survivorship Across the Lifespan$1,936,770
UH3 · FY2023 · CA
(2/3) MMC, VICC, and TSU: Partners in Eliminating Cancer Disparities$1,503,787
U54 · FY2023 · CA · contact PI
IMProving Care After Inherited Cancer Testing (IMPACT) Study$720,549
U01 · FY2023 · CA · contact PI
Enhancing Cancer Care Of Rural Dwellers Through Telehealth and Engagement (ENCORE)$622,074
R01 · FY2023 · CA
Administrative Core$216,728
U54 · FY2023 · CA · contact PI
Expanding Genetic Risk Assessment to Underserved Populations: A Cancer Registry-Based Approach$122,493
U01 · FY2023 · CA · contact PI
IMProving Care After Inherited Cancer Testing (IMPACT) Study$94,754
U01 · FY2023 · CA · contact PI
(2/3) MMC, VICC, and TSU: Partners in Eliminating Cancer Disparities$1,511,193
U54 · FY2022 · CA · contact PI
CAUSAL: Cohort to Augment the Understanding of Sarcoma Survivorship Across the Lifespan$1,050,989
UG3 · FY2022 · CA
Enhancing Cancer Care Of Rural Dwellers Through Telehealth and Engagement (ENCORE)$631,185
R01 · FY2022 · CA
IMProving Care After Inherited Cancer Testing (IMPACT) Study$529,673
U01 · FY2022 · CA · contact PI
Administrative Core$278,779
U54 · FY2022 · CA · contact PI
IMProving Care After Inherited Cancer Testing (IMPACT) Study$225,456
U01 · FY2022 · CA · contact PI
(2/3) MMC, VICC, and TSU: Partners in Eliminating Cancer Disparities$1,550,457
U54 · FY2021 · CA · contact PI
CAUSAL: Cohort to Augment the Understanding of Sarcoma Survivorship Across the Lifespan$1,076,143
UG3 · FY2021 · CA
IMProving Care After Inherited Cancer Testing (IMPACT) Study$794,546
U01 · FY2021 · CA · contact PI
Enhancing Cancer Care Of Rural Dwellers Through Telehealth and Engagement (ENCORE)$657,837
R01 · FY2021 · CA
Breast Cancer In Blacks: Impact of Genomics, Healthcare Use and Lifestyle on Outcomes (BRIGHT)$368,599
R01 · FY2021 · CA · contact PI
Administrative Core$244,511
U54 · FY2021 · CA · contact PI
MMC, VICC, & TSU: PARTNERS IN ELIMINATING CANCER DISPARITIES (2 of 3)$1,107,640
U54 · FY2020 · CA · contact PI
Enhancing Cancer Care Of Rural Dwellers Through Telehealth and Engagement (ENCORE)$863,700
R01 · FY2020 · CA
IMProving Care After Inherited Cancer Testing (IMPACT) Study$816,146
U01 · FY2020 · CA · contact PI
Breast Cancer In Blacks: Impact of Genomics, Healthcare Use and Lifestyle on Outcomes (BRIGHT)$368,599
R01 · FY2020 · CA · contact PI
Enhancing Cancer Care Of Rural Dwellers Through Telehealth and Engagement (ENCORE)$150,000
R01 · FY2020 · CA
MMC, VICC, & TSU: PARTNERS IN ELIMINATING CANCER DISPARITIES (2 of 3)$1,083,735
U54 · FY2019 · CA · contact PI
Enhancing Cancer Care Of Rural Dwellers Through Telehealth and Engagement (ENCORE)$691,805
R01 · FY2019 · CA
Breast Cancer In Blacks: Impact of Genomics, Healthcare Use and Lifestyle on Outcomes (BRIGHT)$357,540
R01 · FY2019 · CA · contact PI
MMC, VICC, & TSU: PARTNERS IN ELIMINATING CANCER DISPARITIES (2 of 3)$1,232,910
U54 · FY2018 · CA · contact PI
Breast Cancer In Blacks: Impact of Genomics, Healthcare Use and Lifestyle on Outcomes (BRIGHT)$368,599
R01 · FY2018 · CA · contact PI
Breast Cancer In Blacks: Impact of Genomics, Healthcare Use and Lifestyle on Outcomes (BRIGHT)$383,100
R01 · FY2017 · CA · contact PI
Clinical Relevance of Mismatch Repair in Ovarian Cancer$132,823
K07 · FY2010 · CA · contact PI
Ovarian Cancer and Mismatch Repair Deficiency$333,818
R01 · FY2009 · CA · contact PI
Clinical Relevance of Mismatch Repair in Ovarian Cancer$132,823
K07 · FY2009 · CA · contact PI
Ovarian Cancer and Mismatch Repair Deficiency$414,533
R01 · FY2008 · CA · contact PI
Clinical Relevance of Mismatch Repair in Ovarian Cancer$132,823
K07 · FY2008 · CA · contact PI
Ovarian Cancer and Mismatch Repair Deficiency$407,566
R01 · FY2007 · CA · contact PI
Clinical Relevance of Mismatch Repair in Ovarian Cancer$132,823
K07 · FY2007 · CA · contact PI
Ovarian Cancer and Mismatch Repair Deficiency$481,228
R01 · FY2006 · CA · contact PI
Clinical Relevance of Mismatch Repair in Ovarian Cancer$132,695
K07 · FY2006 · CA · contact PI
Ovarian Cancer and Mismatch Repair Deficiency$522,611
R01 · FY2005 · CA